CARDINAL HEALTH INC (CAH) Fundamental Analysis & Valuation

NYSE:CAH • US14149Y1082

220.905 USD
+1.81 (+0.83%)
Last: Mar 13, 2026, 10:35 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CAH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

CAH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of CAH get a neutral evaluation. Nothing too spectacular is happening here. CAH is growing strongly while it is still valued neutral. This is a good combination! With these ratings, CAH could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

5

1. CAH Profitability Analysis

1.1 Basic Checks

  • In the past year CAH was profitable.
  • In the past year CAH had a positive cash flow from operations.
  • CAH had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years CAH had a positive operating cash flow.
CAH Yearly Net Income VS EBIT VS OCF VS FCFCAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • CAH's Return On Assets of 2.86% is fine compared to the rest of the industry. CAH outperforms 61.39% of its industry peers.
  • The Return On Invested Capital of CAH (14.50%) is better than 91.09% of its industry peers.
  • CAH had an Average Return On Invested Capital over the past 3 years of 14.18%. This is significantly above the industry average of 8.98%.
  • The last Return On Invested Capital (14.50%) for CAH is above the 3 year average (14.18%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.86%
ROE N/A
ROIC 14.5%
ROA(3y)1.81%
ROA(5y)0.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.18%
ROIC(5y)11.92%
CAH Yearly ROA, ROE, ROICCAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • With a Profit Margin value of 0.68%, CAH perfoms like the industry average, outperforming 53.47% of the companies in the same industry.
  • With a Operating Margin value of 1.20%, CAH is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
  • CAH's Operating Margin has been stable in the last couple of years.
  • With a Gross Margin value of 3.70%, CAH is not doing good in the industry: 79.21% of the companies in the same industry are doing better.
  • CAH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.2%
PM (TTM) 0.68%
GM 3.7%
OM growth 3Y6.46%
OM growth 5Y-0.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.56%
GM growth 5Y-3.96%
CAH Yearly Profit, Operating, Gross MarginsCAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CAH Health Analysis

2.1 Basic Checks

  • CAH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CAH has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CAH has been reduced compared to 5 years ago.
  • CAH has a worse debt/assets ratio than last year.
CAH Yearly Shares OutstandingCAH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CAH Yearly Total Debt VS Total AssetsCAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

  • CAH has an Altman-Z score of 4.84. This indicates that CAH is financially healthy and has little risk of bankruptcy at the moment.
  • CAH has a Altman-Z score of 4.84. This is amongst the best in the industry. CAH outperforms 84.16% of its industry peers.
  • The Debt to FCF ratio of CAH is 1.64, which is an excellent value as it means it would take CAH, only 1.64 years of fcf income to pay off all of its debts.
  • CAH's Debt to FCF ratio of 1.64 is amongst the best of the industry. CAH outperforms 81.19% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.64
Altman-Z 4.84
ROIC/WACC1.77
WACC8.21%
CAH Yearly LT Debt VS Equity VS FCFCAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B 8B

2.3 Liquidity

  • CAH has a Current Ratio of 0.91. This is a bad value and indicates that CAH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.91, CAH is doing worse than 78.22% of the companies in the same industry.
  • A Quick Ratio of 0.44 indicates that CAH may have some problems paying its short term obligations.
  • CAH has a Quick ratio of 0.44. This is amonst the worse of the industry: CAH underperforms 88.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.44
CAH Yearly Current Assets VS Current LiabilitesCAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CAH Growth Analysis

3.1 Past

  • CAH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.32%, which is quite impressive.
  • CAH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.62% yearly.
  • CAH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.13%.
  • The Revenue has been growing slightly by 7.80% on average over the past years.
EPS 1Y (TTM)24.32%
EPS 3Y17.65%
EPS 5Y8.62%
EPS Q2Q%36.27%
Revenue 1Y (TTM)10.13%
Revenue growth 3Y7.06%
Revenue growth 5Y7.8%
Sales Q2Q%18.75%

3.2 Future

  • Based on estimates for the next years, CAH will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.29% on average per year.
  • CAH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.81% yearly.
EPS Next Y26.31%
EPS Next 2Y19.12%
EPS Next 3Y16.66%
EPS Next 5Y15.29%
Revenue Next Year15.83%
Revenue Next 2Y12.36%
Revenue Next 3Y10.82%
Revenue Next 5Y9.81%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CAH Yearly Revenue VS EstimatesCAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B
CAH Yearly EPS VS EstimatesCAH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. CAH Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.99 indicates a rather expensive valuation of CAH.
  • CAH's Price/Earnings ratio is a bit cheaper when compared to the industry. CAH is cheaper than 64.36% of the companies in the same industry.
  • CAH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.71.
  • CAH is valuated rather expensively with a Price/Forward Earnings ratio of 18.89.
  • 61.39% of the companies in the same industry are more expensive than CAH, based on the Price/Forward Earnings ratio.
  • CAH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.99
Fwd PE 18.89
CAH Price Earnings VS Forward Price EarningsCAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CAH is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CAH indicates a rather cheap valuation: CAH is cheaper than 84.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.44
EV/EBITDA 15.12
CAH Per share dataCAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800 1K

4.3 Compensation for Growth

  • CAH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CAH's earnings are expected to grow with 16.66% in the coming years.
PEG (NY)0.87
PEG (5Y)2.67
EPS Next 2Y19.12%
EPS Next 3Y16.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CAH Dividend Analysis

5.1 Amount

  • CAH has a yearly dividend return of 0.95%, which is pretty low.
  • CAH's Dividend Yield is rather good when compared to the industry average which is at 0.49. CAH pays more dividend than 85.15% of the companies in the same industry.
  • With a Dividend Yield of 0.95, CAH pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.95%

5.2 History

  • The dividend of CAH has a limited annual growth rate of 1.25%.
  • CAH has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of CAH decreased recently.
Dividend Growth(5Y)1.25%
Div Incr Years1
Div Non Decr Years1
CAH Yearly Dividends per shareCAH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 29.78% of the earnings are spent on dividend by CAH. This is a low number and sustainable payout ratio.
  • CAH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP29.78%
EPS Next 2Y19.12%
EPS Next 3Y16.66%
CAH Yearly Income VS Free CF VS DividendCAH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
CAH Dividend Payout.CAH Dividend Payout, showing the Payout Ratio.CAH Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CAH Fundamentals: All Metrics, Ratios and Statistics

CARDINAL HEALTH INC

NYSE:CAH (3/13/2026, 10:35:54 AM)

220.905

+1.81 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners90.52%
Inst Owner Change0.88%
Ins Owners0.22%
Ins Owner Change0.12%
Market Cap51.98B
Revenue(TTM)244.67B
Net Income(TTM)1.66B
Analysts83.64
Price Target252.17 (14.15%)
Short Float %2.13%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield 0.95%
Yearly Dividend2.05
Dividend Growth(5Y)1.25%
DP29.78%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-01
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.64%
Min EPS beat(2)9.42%
Max EPS beat(2)15.85%
EPS beat(4)4
Avg EPS beat(4)8.42%
Min EPS beat(4)1.06%
Max EPS beat(4)15.85%
EPS beat(8)8
Avg EPS beat(8)8.46%
EPS beat(12)12
Avg EPS beat(12)10.06%
EPS beat(16)14
Avg EPS beat(16)9.02%
Revenue beat(2)2
Avg Revenue beat(2)4.22%
Min Revenue beat(2)1.38%
Max Revenue beat(2)7.06%
Revenue beat(4)2
Avg Revenue beat(4)1.11%
Min Revenue beat(4)-2.15%
Max Revenue beat(4)7.06%
Revenue beat(8)4
Avg Revenue beat(8)0.45%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)10
Avg Revenue beat(16)0.79%
PT rev (1m)5.75%
PT rev (3m)16.32%
EPS NQ rev (1m)2.2%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)3%
EPS NY rev (3m)4.86%
Revenue NQ rev (1m)-0.86%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 22.99
Fwd PE 18.89
P/S 0.21
P/FCF 9.44
P/OCF 8.52
P/B N/A
P/tB N/A
EV/EBITDA 15.12
EPS(TTM)9.61
EY4.35%
EPS(NY)11.69
Fwd EY5.29%
FCF(TTM)23.4
FCFY10.59%
OCF(TTM)25.93
OCFY11.74%
SpS1039.75
BVpS-12.26
TBVpS-71.66
PEG (NY)0.87
PEG (5Y)2.67
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.86%
ROE N/A
ROCE 19.91%
ROIC 14.5%
ROICexc 17.86%
ROICexgc N/A
OM 1.2%
PM (TTM) 0.68%
GM 3.7%
FCFM 2.25%
ROA(3y)1.81%
ROA(5y)0.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.18%
ROIC(5y)11.92%
ROICexc(3y)25.43%
ROICexc(5y)20.07%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.47%
ROCE(5y)16.36%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y7.19%
ROICexc growth 5Y14.1%
OM growth 3Y6.46%
OM growth 5Y-0.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.56%
GM growth 5Y-3.96%
F-Score7
Asset Turnover4.21
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.64
Debt/EBITDA 2.18
Cap/Depr 67.61%
Cap/Sales 0.24%
Interest Coverage 250
Cash Conversion 159.64%
Profit Quality 331.29%
Current Ratio 0.91
Quick Ratio 0.44
Altman-Z 4.84
F-Score7
WACC8.21%
ROIC/WACC1.77
Cap/Depr(3y)70.24%
Cap/Depr(5y)63.55%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.23%
Profit Quality(3y)467.85%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.32%
EPS 3Y17.65%
EPS 5Y8.62%
EPS Q2Q%36.27%
EPS Next Y26.31%
EPS Next 2Y19.12%
EPS Next 3Y16.66%
EPS Next 5Y15.29%
Revenue 1Y (TTM)10.13%
Revenue growth 3Y7.06%
Revenue growth 5Y7.8%
Sales Q2Q%18.75%
Revenue Next Year15.83%
Revenue Next 2Y12.36%
Revenue Next 3Y10.82%
Revenue Next 5Y9.81%
EBIT growth 1Y29.74%
EBIT growth 3Y13.98%
EBIT growth 5Y6.84%
EBIT Next Year44.08%
EBIT Next 3Y20.02%
EBIT Next 5Y20.36%
FCF growth 1Y60.71%
FCF growth 3Y-13.35%
FCF growth 5Y3.14%
OCF growth 1Y54.19%
OCF growth 3Y-9.47%
OCF growth 5Y4.11%

CARDINAL HEALTH INC / CAH FAQ

Can you provide the ChartMill fundamental rating for CARDINAL HEALTH INC?

ChartMill assigns a fundamental rating of 5 / 10 to CAH.


What is the valuation status for CAH stock?

ChartMill assigns a valuation rating of 5 / 10 to CARDINAL HEALTH INC (CAH). This can be considered as Fairly Valued.


How profitable is CARDINAL HEALTH INC (CAH) stock?

CARDINAL HEALTH INC (CAH) has a profitability rating of 5 / 10.


What is the expected EPS growth for CARDINAL HEALTH INC (CAH) stock?

The Earnings per Share (EPS) of CARDINAL HEALTH INC (CAH) is expected to grow by 26.31% in the next year.


How sustainable is the dividend of CARDINAL HEALTH INC (CAH) stock?

The dividend rating of CARDINAL HEALTH INC (CAH) is 5 / 10 and the dividend payout ratio is 29.78%.